PATENT CLAIM ANALYSIS

Application Number: 15944659
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "094000"]

Abstract:
A novel class of drugs for treating androgen receptor (AR) positive cancer including prostate cancer and breast cancer are described. The drugs include the chemical scaffolds of a high affinity androgen receptor ligand and a histone deacetylase inhibitor. Also described are compositions including the novel drugs and methods of treating AR positive cancer using the compositions.

Claim (Index 4):
A drug of Formula (III), wherein:\n n is 0 to 10; \n A and B are independently, an aryl group or a heteroaryl group; \n X is a CH 2  group, a CH group, a nitrogen atom, an oxygen atom, a sulfur atom, or a carbonyl group; \n Y is a CH 2  group, CH group, a nitrogen atom, an oxygen atom, a sulfur atom, or a carbonyl group; \n  is either present so as to form a double bond, or is absent; \n W is \u2014CF 3 , \u2014CHF 2 , \u2014CH 2 F, \u2014CH 3 , \u2014C 2 H 6 , \n and\n R is a zinc binding group (ZBG).

Metadata:
- Claim Count in Document: 29.0
- Percentile: 91.0
- Lexical Diversity: 1.64865
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15417860', '15346743', '15331777', '15222734', '15457782']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7943104682943425
- 35 USC 102 Novelty (BERT): 0.5812116350887734
- Combined Prediction Score: 0.7730005849737855
- Mean Citation Score: 350.17211000000015
- Max Citation Score: 511.5854
- Similarity Product: 394.1602087192893

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test